Kansas Pharmacy Resident Conference

Have you Registered Yet? Register Online

Presentation Schedule

Working/Tentative Schedule.
Note that this is subject to change

Presentation Abstracts (May, 2021)

Analysis of Response to Poly (ADP-Ribose) Polymerase Inhibitors for Maintenance Treatment of Ovarian Cancer in Patients with Homologous Recombination Deficiency by Jordanne Adolphsen, PharmD

Assessment and implementation of a tool to monitor patient adherence to oral chemotherapy by Marianne Carter, PharmD

Association of Low-Dose Ketamine use with Emergency Department Throughput in Patients with Abnormal Pain by LeFontae McAtee, PharmD

Clinical Pharmacist Impact on Improving Access to Care Virtually Within a Rural Health Clinic by Farrah Zonoozi, PharmD, PGY2 Ambulatory Care Resident

Comparative analysis of dexamethasone dosing strategies in patients with SARS-CoV-2 infection by Mark Caddell, Pharm.D.

Comparing immunization status between ICU and non-ICU admitted patients infected with COVID-19 by Bradley Nash, PharmD

Designing a New Patient to Pharmacist Ratio by Brittanie Wieland, PharmD

Determining Burnout of Pharmacists as Providers by Nicole Henderson, PharmD

Determining Optimal Antifungal Prophylaxis in Acute Myeloid Leukemia Patients Receiving Venetoclax by Taylor Updyke, PharmD

Effect of absolute leukocyte count on efficacy and safety outcomes in immunotherapy combinations by Russell Clark, PharmD

Effect of recent DOAC administration on intravenous heparin monitoring with anti-Xa and aPTT lab assays b y Samuel Hausmann, PharmD

Effectiveness of benzodiazepine symptom-triggered regimen versus fixed-dosing regimen for alcohol withdrawal by Jordan Thoman, PharmD

Effects of Delayed Second Dose Antibiotic Administration in Patients with Septic Shock by Jennifer Walling, PharmD

Effects of Implementing Area Under The Curve (AUC) Vancomycin Dosing On Acute Kidney Injury by Jantz Budde, PharmD

Efficacy Evaluation of Continuous Inhaled Epoprostenol in the Treatment of ARDS, Including SARS-CoV-2 Related ARDS by Hannah Milenkovich, PharmD

Efficacy of Direct Oral Anticoagulants (DOACs) in the Prevention of Recurrent Deep Vein Thrombosis in Obese Veterans versus Veterans of Normal Weight by Hannah Twenhafel, PharmD

Efficiency and Safety of Undiluted Intravenous Push Levetiracetam and Lacosamide by Caitlynn Tabaka, PharmD

Evaluating Clinical Pharmacy Services in an Ambulatory Psychiatry Setting by Belinda Darkwah, PharmD

Evaluating the Impact of Evidence-Based Use of Lactated Ringer's in Patients with Sepsis by Alexander Aliling, PharmD

Evaluation and Implementation of Fixed Dosing Prothrombin Complex Concentrate for Warfarin Reversal by Kristen Haeger-Overstreet, PharmD

Evaluation of a penicillin allergy pharmacy assessment on non-preferred antimicrobial use in a community hospital by Kristen Farnet, PharmD, MBA

Evaluation of enoxaparin dosing for VTE prophylaxis in heavier and underweight populations by Adam Luetkemeyer, PharmD

Evaluation of hospitalizations and emergency department visits for chronic obstructive pulmonary disease (COPD) patients following implementation of 340B prescription assistance program by Leah Taliaferro, PharmD

Evaluation of Initial Gentamicin Dosing in a 36-Bed Neonatal Intensive Care Unit by Carly Redlich, PharmD

Evaluation of Interprofessional Collaboration with Inclusion of Ambulatory Care Pharmacists in a Patient Centered Medical Home Model on Heart Failure and 30-day Readmissions by Kyle Mick, PharmD

Evaluation of medication override practices at a large, academic medical center by Whitney Hessel, PharmD, BCPS

Evaluation of procalcitonin laboratory reference range modification and antimicrobial utilization by Allen Snider, PharmD

Evaluation of Same-Day vs Next-Day Pegfilgrastim in Breast Cancer Patients by Michael Weise, PharmD

Evaluation of a penicillin allergy pharmacy assessment on non-preferred antimicrobial use in a community hospital by Kristen Farnet, PharmD, MBA

Evaluation of the Potential Impacts of an Employer-Sponsored Pharmacist-Led Disease State Management Program by Chris Duphren, PharmD

Evaluation of Thromboelastography in Pediatric Trauma by CJ Wilson, PharmD

Hypertonic Saline versus a Mixed Salt Solution for the Management of Cerebral Edema: A Single-Center Before-and-After Study by Mackenzie Moritz, PharmD

Impact of clinical pharmacists on the work environment in ambulatory care clinics by Amber Thomas, PharmD

Impact of Diluent Overfill on Accuracy of Antineoplastic Preparation and Administration by Amanda Kuhn, PharmD

Impact of Pharmacist Conducted Phone Education on Reduction of Emergency Room Visits in Elderly Veterans Related to New Tricyclic Antidepressant and Paroxetine Use by Lauren Sudhoff, PharmD

Impact of Pharmacist Involvement on Anti-inflammatory Disease Management for Employees by Lauren Schleicher, PharmD

Impact of pharmacist-led education of asymptomatic bacteriuria treatment in a community hospital by Amelia Gooch, PharmD

Impact of Utilization Guidelines on Injectable Hydralazine Use in Hypertensive Crises by Myles Dice, PharmD

Implementation of Tools within the Electronic Medical Record to Support Specialty Pharmacy by John Ho, PharmD

Incidence of CMV Viremia with Mini-Dose Valganciclovir Prophylaxis After Renal Transplantation by Lauren Roder, PharmD

Incidence of deep vein thrombosis (DVT) in pediatric patients with peripherally inserted central catheters (PICC), with and without pharmacologic DVT prophylaxis by Alexa Karels, PharmD

Incidence of post-operative atrial fibrillation with prophylactic amiodarone use in coronary artery bypass graft patients by Sierra Miles, PharmD

Initiation of Antipsychotic Treatment for Amphetamine Induced Psychosis and its Impact on Length of Stay by Claire Herbst, PharmD, BCPS

Inpatient Anemia Management in Heart Failure with Intravenous Iron Replacement by Joshua Mohn, PharmD

Integration of Patient-Aligned Care Team Clinical Pharmacy Specialists in the Interdisciplinary Management of Chronic Obstructive Pulmonary Disease by Kennedy Moore, Pharm.D.

Intravenous Iron Order Set Optimization at a Large Academic Medical Center by Rachael Smith, PharmD

Late Reactivation of Cytomegalovirus With Letermovir Use in Allogeneic Stem Cell Transplant by Liz Hazlett, PharmD

Mission Impossible: Medication Returns in a Heavy De-centralized Pharmacy Department by Shannon Stittsworth, PharmD

One HIT Wonder: Analysis of HIT Management Strategies with Intermediate Antibody Optical Densities by Brad Erich, PharmD

Opioid prescribing pre-post implementation of the pain treatment order set by Hannah Post, PharmD

Optimizing automation and workflow design using an operational mission and vision statement by Erin Boswell, Pharm.D., BCPS

Optimizing Medication Alerts Through Implementation of a Medication Alerts Review Committee by Erika Sieber, PharmD

Oral Cephalosporins versus Fluoroquinolones or Sulfamethoxazole-Trimethoprim for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis: A Nationwide Cohort Study by Patricia Callahan, PharmD

Oral Vancomycin for C. difficile Prophylaxis in Allogenic Hematopoietic Cell Transplant by Olivia Altemeier, PharmD

Outcomes associated with pharmacist-driven MRSA nasal screenings in patients with suspected pneumonia by Justice Oehlert, Pharm.D.

Pharmacist Impact on Transitions of Care in the Family Medicine Clinic by Ethan Leiker, PharmD

Preventing Thromboembolic Events in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients Using Heparin or Enoxaparin at Therapeutic doses by Deina Khader, PharmD

Safety analysis of sodium-glucose co-transporter 2 inhibitor administration in an inpatient setting by Melinda Johnson, Pharm.D.

The Effect of Shifting Preferred Anti-Pseudomonal Pneumonia Coverage on Clinical Outcomes and Safety by Kyle Klindworth, PharmD

The Impact of Job Instruction Training Within Pharmacy by Faria Munir, PharmD

The Impact of Transitions of Care Pharmacist Interaction on 30 Day Readmission Rates in Medium and High-Risk Patients by Emily Mueller, PharmD

Timing of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients with Septic Shock by Allison Brask, PharmD

Treatment Duration of Enterobacterales Bacteremia by Chelsea Love, PharmD

Use of an Electronic Database to Evaluate Performance of Anticoagulation by Mariah Black, PharmD

Utilizing Clinical Pharmacists and a Medication Assistance Program to Improve Medication Access for Indigent and Underserved Patients in Primary Care by Brianna Long, PharmD

Vancomycin Troughs Before and After Implementation of a Standardized Neonatal ICU Dosing Protocol by Samuel Dold, PharmD

Copyright 2019, Kansas Council of Health-System Pharmacy (KCHP)
Kansas Council of Health-System Pharmacy is a 501(c)6 non-profit organization. 2650 S. Hanley Rd., Suite 100, St. Louis, MO 63144
Phone: (314) 416-2247 | Fax: (314) 845-1891 | email: KCHP@QABS.COM
Powered by Wild Apricot Membership Software